Western GeoPower is incorporated in the province of British Columbia, Canada and is a reporting issuer in the provinces of British Columbia, Alberta and Ontario. The company's shares are listed on the TSX Venture Exchange in Canada. "Western GeoPower Corp. is focused on developing the South Meager Project as Canada's first commercial geothermal power generating facility for electricity, with a development potential of 100-250 MW of electricity." The South Meager Geothermal Project is owned and operated by Meager Creek Development Corp.

Oscient Pharmaceuticals Corporation, a commercial-stage biopharmaceutical company, sells and markets products to community-based primary care physicians through its national primary care sales force in the United States. It markets cardiovascular product, ANTARA (fenofibrate) capsules to treat hypercholesterolemia (high blood cholesterol) and hypertriglyceridemia (high triglycerides) in combination with a healthy diet; and FACTIVE (gemifloxacin mesylate), a fluoroquinolone antibiotic tablet for the treatment of community-acquired pneumonia of mild to moderate severity and acute bacterial exacerbations of chronic bronchitis.

eTelcharge.com (OTC BB:ETLC.OB - News) offers the traditional credit card merchant services, checks and other existing financial infrastructure offered by banks, as well as the proprietary new online currency that will provide online shoppers the exclusive choice to charge approved transactions to their telephone bill. Designed to reduce the risk of identity fraud and identity theft by providing an Internet credit option for online shoppers to charge consumer transactions on the Internet. This payment option is a perfect match for the millions of individuals who do not own a credit card. eTelcharge.com started as the only company with the ability to charge a variety of products to the home phone bill. Clearly, past electronic commerce solutions have not employed effective security and privacy techniques that adequately address consumer concerns about privacy and security on the Internet today. The release of the latest version of the proprietary phone billing option is scheduled to be launched soon.

Selwyn Resources Ltd. is a publicly traded, Canadian base-precious metals exploration and development company. The company's core project is the World class Selwyn Project, located in eastern Yukon. The project has reactivated the Howard's Pass zinc-lead district, and since 2005 the company has spent over $25 million on exploration, development and environmental programs.

Great Western Minerals Group Ltd. (formerly Great Western Gold Corp.) was incorporated in 1983 in the Province of British Columbia, Canada. It has been trading publicly since 1984, and is currently trading on the TSX Venture Exchange (TSX) under the symbol "GWG". In 1999, under the direction of new management, the Company redefined its resource exploration objectives to actively expand its project portfolio to include strategic metals as well as diamonds.

ROMIOS GOLD RESOURCES INC., is a Canadian exploration company which focuses on the acquisition and exploration of precious and base metal prospects within or in close proximity to major mining camps throughout North America. ROMIOS GOLD currently holds several high potential projects and since 2004 has acquired an extensive land position between two significant mineral deposits in northwestern British Columbia, Canada: NovaGold’s billion-tonne Galore Creek Project and Barrick’s Eskay Creek high-grade mine.

WaferGen is focused on the development of state of the art systems for gene expression, genotyping and stem cell research for the life science and pharmaceutical industries. WaferGen's products are aimed at professionals who perform genetic analysis and cell biology, primarily at pharmaceutical and biotech companies, academic and private research centers and diagnostics companies involved in biomarker research.

Queenston Mining Inc. is a Canadian resource company focused on the exploration and development of gold deposits on “Proven Mine Trends”. The Company is a past producer with an inventory of historic-current resources of 2 million ounces of gold. With new discoveries in the Kirkland Lake and Cadillac gold camps the Company is closer to its goal of returning to producer status.

The primary Objective for MBS is to market innovative building construction technologies and products that improve the efficiency of residential and commercial structures.

Midlands Minerals Corporation is a growth oriented junior diversified mineral exploration company - with vision - whose primary focus is on gold and diamonds in Ghana and Tanzania. Management has worked in the region for over 20 years with 10 years of experience in exploration and development including operating small scale gold recovery plants in the region.

Xenomics is a molecular diagnostic company that has a unique opportunity to change the practice of Medicine. Based on its unusually broad and powerful intellectual property, the Company has developed a new approach to molecular diagnostic testing that uses simple and safe urine specimens in place of invasive and hazardous specimens including blood, sputum, or tissue biopsies.

Pan African Mining Corp. and its subsidiaries acquire, explore and develop mineral properties in areas of Africa deemed to have relatively high potential for mining success and relatively low political risk. The Company currently has approximately 10,000 square kilometres of diversified mineral properties in Madagascar.

Bradmer Pharmaceuticals is a biotechnology company focused on the development and commercialization of new and innovative cancer therapies. Bradmer’s lead clinical candidate, Neuradiab, was developed at Duke University Medical Center as a proprietary therapy for a particularly aggressive form of brain cancer. To date, over US$60 million has been spent on research and development of the licensed treatment, which has been used in over 160 patients with excellent results and has completed Phase II clinical trials conducted by researchers at Duke University. Bradmer is currently in the process of organizing a multi-center clinical trial of the licensed treatment. Neuradiab was recently granted Orphan Drug Status by the U.S. Food and Drug Administration.

Nevada Geothermal Power holds a 100% interest in 15.0 square miles/39 square-kilometres of geothermal leases just west of Winnemucca in north central Nevada.